Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines - a possible link between reduced skin barrier function and inflammation?-Reference-Cited by-同舟云学术

Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines - a possible link between reduced skin barrier function and inflammation?

Published:2011-05-04 Issue:8 Volume:20 Page:633-636
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:

Author:

Hvid Malene,Johansen Claus,Deleuran Bent,Kemp Kaare,Deleuran Mette,Vestergaard Christian

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0625.2011.01280.x/fullpdf

Reference17 articles.

1. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

2. Filaggrin in the frontline: role in skin barrier function and disease

3. Caspase-14 protects against epidermal UVB photodamage and water loss

4. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing

5. Caspase-14 reveals its secrets

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue-specific and functional loci analysis ofCASP14gene in the sheep horn;2024-09-07

2. Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology;Communications Medicine;2024-06-11

3. Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia;Biomedicine & Pharmacotherapy;2024-04

4. “Outside-to-inside,” “inside-to-outside,” and “intrinsic” endogenous pathogenic mechanisms in atopic dermatitis: keratinocytes as the key functional cells involved in both permeability barrier dysfunction and immunological alterations;Frontiers in Immunology;2023-08-11

5. Advances in Current Drugs and Formulations for the Management of Atopic Dermatitis;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023